The hypercoagulability observed in GBM arises from multiple factors, including vascular abnormalities, overexpression of tissue factor (TF) and podoplanin (PDPN), and the release of procoagulant extracellular vesicles (EVs) [6]. This evidence concerns the gene F3 and glioblastoma.